Last updated on August 2020

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis


Brief description of study

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

Clinical Study Identifier: NCT03952559

Find a site near you

Start Over

Fundacion CIDEA

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Instituto de Neumonolog a y Dermatolog a

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Center of Children`s Health

Moscow, Russian Federation
  Connect »

Hospital Sant Joan de D u

Esplugues de Llobregat, Spain
  Connect »

Care Hospital

Hyderabad, India
  Connect »

Centro Medico Dra. De Salvo

Capital Federal, Argentina
  Connect »

Kume Clinic

Nishi-ku Sakai-shi, Japan
  Connect »

St Thomas's Hospital

Waterloo, United Kingdom
  Connect »

Kozni oddeleni

Novy Jicin, Czechia
  Connect »

Instituto de Neumonolog a y Dermatolog a

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Hospital Sant Joan de D u

Esplugues de Llobregat, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.